Empresa Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board
Acciones
US21833P1030
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
13/05 | CORBUS PHARMACEUTICALS HOLDINGS, INC. : Recibe una recomendación de compra del RBC Capital Markets | ZM |
08/05 | CORBUS PHARMACEUTICALS HOLDINGS, INC. : recomendación de compra de Oppenheimer | ZM |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01/07/13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 11/04/14 |
Chief Tech/Sci/R&D Officer | 50 | 28/02 | |
Human Resources Officer | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 01/01/14 |
Avery Catlin
BRD | Director/Board Member | 75 | 01/08/14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01/07/13 |
John Jenkins
BRD | Director/Board Member | 66 | 05/06/18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 08/04/19 |
Yong Ben
BRD | Director/Board Member | 50 | 01/03/23 |
Peter Salzmann
BRD | Director/Board Member | 56 | 06/03/20 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 20/09/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 10 686 693 | 10 613 932 ( 99,32 %) | 0 | 99,32 % |
Información de la empresa
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-1,05 % | 21,96 mil M | |
-14,15 % | 21,87 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |
- Bolsa de valores
- Acciones
- Acción CRBP
- Acción
- Empresa Corbus Pharmaceuticals Holdings Inc